Anti-Inflammatory Agents/therapeutic use; Ethanolamines/therapeutic use; Inflammation/drug therapy; Palmitic Acids/therapeutic use; Administration, Oral; Amides; Amidohydrolases/antagonists & inhibitors; Amidohydrolases/physiology; Animals; Anti-Inflammatory Agents/administration & dosage; Anti-Inflammatory Agents/pharmacokinetics; Antidepressive Agents/administration & dosage; Antidepressive Agents/therapeutic use; Biological Availability; Biotransformation; Depression/drug therapy; Disease Models, Animal; Drug Combinations; Ethanolamines/administration & dosage; Ethanolamines/pharmacokinetics; Ethanolamines/pharmacology; Homeostasis; Humans; Inflammation/immunology; Inflammation/physiopathology; Luteolin/administration & dosage; Luteolin/therapeutic use; Mast Cells/immunology; Mast Cells/metabolism; Mast Cells/pathology; Neurocognitive Disorders/drug therapy; Neurocognitive Disorders/pathology; Neuroglia/immunology; Neuroglia/metabolism; Neuroglia/pathology; Neuroimmunomodulation/drug effects; Neuroimmunomodulation/immunology; Palmitic Acids/administration & dosage; Palmitic Acids/pharmacokinetics; Palmitic Acids/pharmacology; Particle Size; Spinal Cord Injuries/drug therapy; Spinal Cord Injuries/pathology